Plenary

Panel Discussion: Triple Therapy vs. Chemotherapy/ADT for Newly Diagnosed mHSPC Patients (Treatment intensification)

Moderator(s)

• 

  Michael S. Cookson, MD (he/him/his)

  Professor and Chair
  University of Oklahoma

Panelist(s)

• 

  Maha Hussain, MD, FACP, FASCO (she/her/hers)

  Northwestern University Feinberg School of Medicine
• EY

  Evan Y. Yu, MD (he/him/his)

  Professor
  Fred Hutchinson Cancer Center
• 

  Robert Dreicer, MD (he/him/his)

  University of Virginia School of Medicine
• 

  Alicia Morgans, MD, MPH, FASCO (she/her/hers)

  Associate Professor of Medicine
  Harvard Medical School